| Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy W Leconet, C Larbouret, T Chardès, G Thomas, M Neiveyans, M Busson, ... Oncogene 33 (47), 5405-5414, 2014 | 62 | 2014 |
| Therapeutic activity of anti-AXL antibody against triple-negative breast cancer patient-derived xenografts and metastasis W Leconet, M Chentouf, S Du Manoir, C Chevalier, A Sirvent, I Aït-Arsa, ... Clinical Cancer Research 23 (11), 2806-2816, 2017 | 40 | 2017 |
| Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump T Mazard, A Causse, J Simony, W Leconet, N Vezzio-Vie, A Torro, ... Molecular cancer therapeutics 12 (10), 2121-2134, 2013 | 40 | 2013 |
| Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with anti-CD3 AA Mamchak, Y Manenkova, W Leconet, Y Zheng, JR Chan, CL Stokes, ... Diabetes 61 (6), 1490-1499, 2012 | 38 | 2012 |
| Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation Y Lazrek, O Dubreuil, V Garambois, N Gaborit, C Larbouret, ... Neoplasia 15 (3), 335-IN40, 2013 | 34 | 2013 |
| HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models G Thomas, T Chardès, N Gaborit, C Mollevi, W Leconet, B Robert, ... Oncotarget 5 (16), 7138, 2014 | 33 | 2014 |
| CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib‐resistant chronic myeloid leukaemia R Gioia, C Trégoat, PY Dumas, V Lagarde, V Prouzet‐Mauléon, V Desplat, ... The Journal of Pathology 237 (1), 14-24, 2015 | 22 | 2015 |
| Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes W Leconet, P Petit, S Peraldi-Roux, D Bresson Molecular Therapy 20 (12), 2315-2325, 2012 | 11 | 2012 |
| Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment DP Nguyen, PL Xiong, H Liu, S Pan, W Leconet, V Navarro, M Guo, J Moy, ... Molecular Cancer Research 14 (11), 1045-1053, 2016 | 10 | 2016 |
| Anti-PSMA/CD3 bispecific antibody delivery and antitumor activity using a polymeric depot formulation W Leconet, H Liu, M Guo, S Le Lamer-Déchamps, C Molinier, S Kim, ... Molecular cancer therapeutics 17 (9), 1927-1940, 2018 | 7 | 2018 |
| Anti-Axl antibodies and uses thereof B Robert, B Fauvel, G Cheve, A Yasri, C Larbouret, W Leconet, T Chardes, ... US Patent 9,409,988, 2016 | 3 | 2016 |
| Anti-Axl antibodies and uses thereof B Robert, B Fauvel, G Cheve, A Yasri, C Larbouret, W Leconet, T Chardes, ... US Patent 9,249,228, 2016 | 3 | 2016 |
| HER3 expression as a predictive biomarker of the efficacy of pertuzumab in pancreatic cancer G Thomas, N Gaborit, W Leconet, B Robert, T Chardes, A Pelegrin, ... ANNALS OF ONCOLOGY 23, 40-40, 2012 | 1 | 2012 |
| External Beam Irradiation May Increase the Therapeutic Index of J591 Brachytherapy MK Ramirez-Fort, S Pan, H Liu, V Navarro, J McCormick, M Guo, ... International Journal of Radiation Oncology• Biology• Physics 99 (2), E261-E262, 2017 | | 2017 |
| Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis N Radosevic-Robin, W Leconet, M Chentouf, S Du Manoir, C Chevalier, ... | | 2017 |
| Melanoma Induces Endothelial Folate Hydrolase-1 (FOLH1) Expression and Facilitated Internalization of Immunotheragnostic Agent, J591 MK Ramirez-Fort, B Meier, JR Vissicchio, J Moy, H Liu, E Contassot, ... International Journal of Radiation Oncology• Biology• Physics 96 (2), E703-E704, 2016 | | 2016 |
| 253 Induction of prostate-specific membrane antigen expression (PSMA) expression and internalization of anti-PSMA monoclonal antibodies in human endothelial cells TPD Nguyen, P Xiong, S Pan, H Liu, M Guo, W Leconet, V Navarro, S Kim, ... European Urology Supplements 3 (15), e253, 2016 | | 2016 |
| CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia: CBL controls kinase expression R Gioia, C Trégoat, PY Dumas, V Lagarde, V Prouzet-Mauléon, V Desplat, ... | | 2015 |
| Folate hydrolase-1 (FOLH1) as a specific therapeutic target for tumor neovasculature in malignant melanoma MK Ramirez-Fort, H Liu, BD Robinson, S Kim, W Leconet, V Navarro, ... JOURNAL OF INVESTIGATIVE DERMATOLOGY 135 (8), S6-S6, 2015 | | 2015 |
| Signalisation et ciblage thérapeutique du récepteur tyrosine kinase AXL dans les cancers W Leconet Montpellier 1, 2014 | | 2014 |
Thierry ChardèsResearch Director, DR1 CNRS, PhD, PharmDDirección de correo verificada de inserm.fr
